Agreed. I think this is half the problem at least. Perhaps we should be looking elsewhere, yes I have no doubt we could easily recruit in the USA with financial inducements and it is the intent to run the 2nd trial there, but although there are regulatory hurdles to overcome maybe the 1st trial should be considered for there also. Alternatively, Eastern Europe ( with financial inducements). I am invested in one ASX biotech now that has done its first clinical trials in an East European country to assess safety, the trial was done in next to no time and no probs getting recruitment, was successful, and today based on that the USA FDA has approved further trialling ( in the USA) as reported in todays announcement. Now thats how you do it !!!
- Forums
- ASX - By Stock
- Interesting
Agreed. I think this is half the problem at least. Perhaps we...
- There are more pages in this discussion • 1,059 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online